Market

Analysis-Innovent’s weight-loss drug highlights China challenge for Novo, Lilly 

Analysis-Innovent’s weight-loss drug highlights China challenge for Novo, Lilly 
Read More

Related Posts

Norsk Hydro shares rise despite mixed Q4 guidance

Norsk Hydro shares rise despite mixed Q4 guidance

Earnings call transcript: Topps Tiles Q2 2025 misses EPS forecast, stock drops

Earnings call transcript: Topps Tiles Q2 2025 misses EP...

Krna Matthew buys C1 Fund Inc (CFND) stock worth $10,005

Krna Matthew buys C1 Fund Inc (CFND) stock worth $10,005

German industrial orders rise more than expected in October

German industrial orders rise more than expected in Oct...

US owner of major Russian agriculture firm says no plans to sell up

US owner of major Russian agriculture firm says no plan...

DocuSign stock price target lowered to $80 from $92 at Evercore ISI

DocuSign stock price target lowered to $80 from $92 at ...